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Background. Compared with the well-studied 5-methylcytosine (m5C) in DNA, the role and topology of epitranscriptome m5C
remain insuﬃciently characterized. Results. Through analyzing transcriptome-wide m5C distribution in human and mouse, we
show that the m5C modiﬁcation is signiﬁcantly enriched at 5′ untranslated regions (5′UTRs) of mRNA in human and mouse.
With a comparative analysis of the mRNA and DNA methylome, we demonstrate that, like DNA methylation, transcriptome
m5C methylation exhibits a strong clustering eﬀect. Surprisingly, an inverse correlation between mRNA and DNA m5C
methylation is observed at CpG sites. Further analysis reveals that RNA m5C methylation level is positively correlated with both
RNA expression and RNA half-life. We also observed that the methylation level of mitochondrial RNAs is signiﬁcantly higher
than RNAs transcribed from the nuclear genome. Conclusions. This study provides an in-depth topological characterization of
transcriptome-wide m5C modiﬁcation by associating RNA m5C methylation patterns with transcriptional expression, DNA
methylations, RNA stabilities, and mitochondrial genome.
1. Introduction
DNA methylation is a well-established and extensively stud-
ied epigenetic phenomenon [1–4]. In contrast, mRNA meth-
ylation is still relatively an uncharted territory [5]. Although
the presence of the chemical modiﬁcations to tRNA has been
established in the 1970s [6–8], little is known about the epi-
genetic modiﬁcations to mRNA and other noncoding RNAs.
Even less was known about their abundance, role, and mode
of regulation until recently when several studies showed that
N6-methyladenosine (m6A) is the most abundant messenger
RNA (mRNA) modiﬁcation in eukaryotes [9], and suggested
to regulate a number of biological processes including trans-
lation eﬃciency [10], circadian clock [11], microRNA pro-
cessing [12], RNA-protein interaction [13], RNA stability
[14], heat shock response [15], and diﬀerentiation [16].
Compared to m6A, even little is known about the abun-
dance and role of transcriptome 5-methylcytosine (m5C)
modiﬁcation. Existing studies of m5C in cellular RNA have
been largely conﬁned to rRNA and tRNA [17]. For example,
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RNAm5C modiﬁcation in plant rRNA and tRNA is reported
to be conserved [18] and is shown to aﬀect the stability of
synthetic RNA [19, 20]. In the mammalian system,
cytosine-5 methylation in tRNA has been shown to regulate
Mg2+ binding, anticodon stem-loop conformation, and sec-
ondary structure stabilization [21, 22]. In addition, m5C in
tRNAs is reported to regulate protein translation in stress
response, tissue diﬀerentiation, and neurodevelopment dis-
orders [23–29]. In rRNA, m5C is shown to regulate the trans-
lation process [30]. A recent study also showed that hm5C,
the intermediate of RNA m5C demethylation, is enriched in
poly(A)-tailed RNA and the coding sequences of the mRNA
transcript, and it is associated with brain development and
the active transcription of mRNA [11].
A recent advancement of the RNA bisulﬁte-sequencing
(BS-Seq) technique [31–34] has enabled the transcriptome-
wide m5C proﬁling at single-base resolution and conﬁrmed
its widespread existence in the human transcriptome
[34, 35]. Intriguing diﬀerences with respect to the degree
of transcriptome m5C methylation, functional classiﬁcation,
and position bias were reported with this technique [36],
and it was recently shown that transcriptome m5C promotes
mRNA export through methyltransferase NSUN2 and reader
ALYREF [37].
It is observed that m5C modiﬁcation may account for
20% of the total internal methylations on poly(A) RNA in
the BHK21 cell line [38, 39]. However, it is not clear whether
the transcriptome m5Cmodiﬁcation is diﬀerentially enriched
in diﬀerent cell types, and the topological relationship
between RNA methylation and DNA methylation under
the same cell lines has not been investigated.
In this study, using the BS-Seq approach, we identiﬁed
transcriptome-wide mRNA m5C methylome in mouse and
human cells. Our results revealed that transcriptome m5C is
enriched and conserved at the 5′UTRs of target transcripts
in both human and mouse cells. Interestingly, under all the
examined cell lines, we observed a negative correlation of
the methylation patterns between RNA m5C methylation
and DNA m5C under the CpG context, and the RNA m5C
methylations are enriched on mitochondrial transcriptome.
2. Material and Methods
2.1. Sample Preparation and RNA Bisulﬁte Sequencing.
MCF10A normal mammary epithelial cells and MDA-
MB-468 breast cancer cells were obtained from ATCC.
MCF10A cells were cultured and maintained in DMEM/
F12 (Life Technologies, USA) supplemented with 5% horse
serum, EGF (20ng/ml), hydrocortisone (0.5μg/ml), insulin
(10μg/ml), and anti-anti (Life Technologies, USA). Like-
wise, MDA-MB-468 cells were cultured in RPMI (Life
Technologies, USA) supplemented with 10% FBS and
anti-anti (Life Technologies, USA). For BS-Seq, total
RNA was isolated from MCF10A and MDA-MB-468 cells
and enriched for poly(A)+ RNA using poly(A) selection
kits. The puriﬁed RNA is subjected to sodium bisulﬁte
treatment at 60 degrees for 8 hours. The bisulﬁte-treated
RNA was then reverse transcribed and subjected to deep
sequencing using the Illumina RNA-Seq protocol. The
data has been deposited under Gene Expression Ominous
(GEO) with Accession Number GSE84230. To replenish
the transcriptome BS-Seq data of the aforementioned
human samples (MCF10A and MDA-MB-468), additional
datasets are obtained from public resources, including
DNA BS-Seq data from MCF10A (GEO GSM659628)
[40], transcriptome m5C methylation data from mouse
embryo stem cells (ESCs) and mouse whole brain proﬁled
by RNA BS-Seq (GEO GSE83432) [36], and mouse ESC
DNA methylation data (GSM1873374) [7, 41].
2.2. Quality Control and Alignment of BS-Seq Data. The
FASTQ ﬁles from BS-Seq samples are trimmed with Trim
Galore [42], it removes low-quality 3′ ends with a Phred
score threshold of 20, and it can remove potential adaptor
contamination. Then, the reads are aligned to the refer-
ence genomes of mouse and human (mm10 and hg19)
with MeRanGs in MeRanTK [43]. The methylation is called
using MeRanCall, and regions of the 5′ ends and 3′ ends of
the reads are ignored based on the threshold cutoﬀ suggested
by the M-bias plot generated by MeRanGs. The minimum
read coverage for the methylation report was set at 10,
and the minimum read base quality (Phred score) for
methylation call is ﬁltered at 30. The maximum read
duplication level is set at 10 to prevent the PCR artefacts;
the minimum nonconversion rate to report is set at 0 to
include the nonmethylated sites as background control
for further analysis.
For DNA bisulﬁte samples, the trimmed reads are
aligned using Bismark under the following alignment
setting: –score_min L,0,-0.6. The SAM ﬁles are ﬁltered by
Samtools using -F 1540 and -q 30 to remove reads that are
duplicated and quality scores that are lower than 30. The
methylation status of genome-wide cytosine sites is reported
from the ﬁltered SAM ﬁles with the Bismark methylation
extractor using the following argument: –cytosine report.
Also, the conversion rate biased ends are also ignored during
methylation call based on the M-bias plots. The minimum
read coverage was ﬁltered at 10 as well.
2.3. Filtering False Positive m5C Sites due to RNA Secondary
Structure. It is known that secondary structures on RNAs
prohibit bisulﬁte conversion and thus can result in false
positive detection of transcriptome m5C sites. As shown
in Figure S1, the detected m5C sites from MeRanTK are
enriched with double-stranded regions of RNA, which
are likely to be false positive errors due to a secondary
structure. For this reason, an R package rBS2ndStructure
was created to facilitate the elimination of the false positive
methylation calls due to RNA secondary structures.
Speciﬁcally, the RNA secondary structure is predicted with
RNAfold from the Vienna RNA package [44] as it was
performed by Amort et al. [36]. The transcriptome-wide
full-length transcripts are extracted from UCSC gene
annotation for both mm10 and hg19. Then, the double-
stranded structures are predicted with the MEA method
under alpha=0.1. The folding temperature is set at 70
degrees, and the maximum pairing distance is set at 150 bp.
For the mitochondrial chromosome and transcripts longer
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than 8000 bp, the structures are predicted using sliding
windows of 2000 bp and step size of 1000 bp. For both the
RNA and the DNA methylation reports, the methylation
sites overlapped with the predicted regions of secondary
structures are ﬁltered. Due to the lack of computational
resources to predict structures on large intronic sequences,
the cytosine sites that do not locate on the exons of known
transcripts or the mitochondrial chromosome are ﬁltered.
The resulting methylation reports are then analyzed under
the R environment using primarily GenomicFeatures [45],
Guitar [46], and ggplot2 [47] packages.
The rBS2ndStructure package is publically available at
Github (https://github.com/ZhenWei10/rBS2ndStructure)
with precomputed RNA secondary structures of genome
assembly mm10 and hg19 for convenient processing of
RNA BS-Seq result.
2.4. Quantitative Analysis of Methylation Status. The
methylation ratio (mRatio) of a speciﬁc cytosine site is
calculated by
Methylation ratio = #of unconverted Cs#of unconverted Cs + #of converted Cs ,
1
where “# of unconverted Cs” and “# of converted Cs”
indicates the count of methylated (unconverted) Cs and
unmodiﬁed Cs (converted Cs) at a speciﬁc cytosine site,
respectively. The methylation rate is conceptually similar
to the well-adapted concept of “beta value” in DNA meth-
ylation analysis [48], which indicates the percentage of
methylated Cs among all Cs. Also, it is not diﬃcult to
show that
Methylation ratio = #of unconverted C#of unconverted C + #of convertedC
= 1 − #of converted C#of unconverted C + #of converted C
= 1 − convertion rate,
2
where the conversion rate has been previously deﬁned in
[35] and a smaller value suggests a higher percentage of
RNA m5C methylation.
To diﬀerentiate a set of statistically signiﬁcantly methyl-
ated cytosine sites against potential technical randomness
due to incomplete bisulﬁte conversion, the p values for the
methylation state of both the DNA and RNA methylation
are calculated by Fisher’s exact test against the background
conversion odds after the ﬁltering of the sites mapped to
introns and secondary structures. The adjusted p values
(FDR) are then adjusted by the Benjamin & Hochberg
method. The positive methylation states were decided when
FDR< 0.05.
For the mouse samples containing 3 biological repli-
cates, the methylated sites are judged as FDR< 0.05 among
all 3 replicates. For other insigniﬁcant methylated sites to
be kept in the analysis, the sites should be reproduced 3
times with coverage> 10. The converted reads and non-
converted reads are added on each site when combining
the biological replicates.
The background bisulﬁte nonconversion rate is 2.75%,
2.74%, 1.18%, and 0.81% for MCF10A, MDA468, mouse
ESC, and mouse brain samples, respectively (taking the aver-
age for samples with more than one biological replicate). The
diﬀerence among nonconversion rates might be due to the
biological diﬀerence of cell lines, batch variation, and diﬀer-
ent BS-Seq protocols.
2.5. Diﬀerential Methylation Analysis. The odds ratio (OR) or
methylation fold change fromdiﬀerential analysis is deﬁned as
Odds ratio (or methylation fold change) indicates
whether the methylation is enriched under one condition
compared with another condition. A value greater than 1
suggests increased methylation level, where as a value less
than 1 suggests decreased methylation level. The statistical
signiﬁcance of the odds ratio is evaluated by the QNB
method, which tests the homogeneity of association
between methylated and unmodiﬁed molecules under two
experimental conditions with the within-group variability
assessed through 4 cross-linked negative binomial
distributions [49].
Similar to the odds ratio from diﬀerential methylation
analysis, the enrichment odds ratio of m5C sites within a
speciﬁc region can be deﬁned as
Enrichment odds ratio = #of m
5C sites within a region/#of C sites within a region
total#of m5C sites/total#of C sites 4
Odds ratio from dif ferential methylation = #of unconverted Cs under cond 1/#of converted Cs under cond 1#of unconverted Cs under cond 2/#of converted Cs under cond 2 3
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A value greater than 1 suggests that methylation sites are
enriched within the tested region, and the statistical signiﬁ-
cance of enrichment can be evaluated by Fisher’s exact test.
Please note that, in this analysis, we used the total number
of cytosine sites reported from MeRanTK rather than the
total number of all 4 types of nucleotides.
2.6. Assessing the Distribution of m5C Sites on mRNA. The
distribution pattern of m5C sites on mRNA is assessed with
the Guitar R/Bioconductor [46]. Compared with other soft-
ware tools and methods, the Guitar package provides an
improved resolution by relying on only the mRNA tran-
scripts that simultaneously have suﬃcient long (more than
100 bp) 5′ UTRs, CDSs, and 3′ UTRs. For instance, tran-
scripts without annotated 5′UTRs will be excluded from the
analysis. Additionally, Guitar does not rely on only the pri-
mary transcript (often deﬁned as the longest transcript
among all isoforms in practice) when solving an ambiguous
association between a m5C site and the isoform transcripts
of a gene; instead, all ambiguous associations are considered
with the weight of association evenly divided. For example, if
a single m5C site locates on the 3′UTR of a transcript and
CDS of another isoform transcript of that gene, it is counted
as if half of the m5C site is located on the 3′ UTR and the
other half located on 5′ UTR. In this way, the isoform infor-
mation is largely retained. To our knowledge, the Guitar
package should provide the most accurate assessment of a
transcriptomic distribution pattern.
2.7. Diﬀerential Expression Analysis. Diﬀerential expression
analysis was performed with the DESeq2 package [50] and
the aligned RNA BS-Seq data.
2.8. Cell Culture and Viral Infection. Jurkat T lymphocytes
were maintained in RPMI 1640 medium (Hyclone)
supplemented with 5% (v/v) FBS (Gibco) and 100U/ml
penicillin/streptomycin (Hyclone). For infection, Jurkat cells
were infected with known amounts (3× 108 genome copies
per 2× 105 cells) of SRV for 18 hours at 37°C, followed by
washing three times with PBS (Hyclone). Infected cells were
incubated in completed culture medium for the indicated
time. Successful infection was identiﬁed as the appearance of
cytopathic eﬀects in infected cells at 8 to 10 days postinfection.
2.9. Reverse Transcription and Real-Time PCR. SRV genome
in culture medium was extracted by viral RNA extraction kit
(TIANGEN) and reverse transcripted into cDNA by a
reverse transcriptase PCR kit (TaKaRa). Cellular genome
was extracted by a TIANamp Genomic DNA Kit (TaKaRa).
Real-time PCR was performed in a 7500 Fast Real-Time
PCR System (Applied Biosystems) by using a Premix Ex
Taq (Probe qPCR) kit (TaKaRa). SRV genome positive con-
trol, primers, and probe, as well as GAPDH primers and
probe were kindly provided by VRL China Ltd. [51].
2.10. Immunoﬂuorescence Assay. Cells were seeded on poly-
L-lysine (Sigma) coated slides, ﬁxed with 4% paraformalde-
hyde for 15 minutes, permeabilized with precold pure
methanol for 20min at −20°C, and blocked with 5% BSA
for 1 hour. Cells were then stained with the serum from an
SRV-infected monkey (1 : 25 diluted in blocking buﬀer)
overnight and visualized with DyLight™ 488-Labeled Anti-
Human antibody (KPL). Cells were counterstained with
Hoechst (Life Technologies) for 10 minutes and mounted
on microscopy slides. Samples were imaged with a ZEISS
LSM 880 Confocal Laser Scanning Microscope.
3. Results
3.1. Overview of mRNA m5C Methylome Revealed by BS-Seq.
After successful processing of the RNA BS-Seq datasets, a
total of 3440 (0.40%), 1915 (0.29%), 35,246 (0.757%), and
25,301 (0.50%) RNA cytosine sites were identiﬁed as m5C
methylation (FDR< 0.05) sites in MCF10A, MDA-MB-468,
mouse embryonic stem cell (ESC), and mouse whole brain,
respectively. The overall transcriptome m5C methylation
level was much lower than the DNA m5C methylation level
(Figure S2). Importantly, we found that m5C was widespread
in diﬀerent RNA families, where more than 50% of them
were located on mRNA (Figure 1(a)). In MCF10A cells, 7131
protein-coding genes had sites reported after the ﬁltering, of
which 225 (3.15%) mRNAs contained m5C sites. In MDA-
MB-468 cells, 6320 protein-coding genes had reads aligned,
of which 128 (2.06%) contained m5C sites. In ESC and brain
samples, the methylation status was available for 11,325 and
13,108 protein-coding genes, of which 3579 (31.6%) and 3065
(23.4%) contained m5C sites. The diﬀerence in number of
m5C sites between diﬀerent conditions is mostly due to
diﬀerent sequencing depth.
3.2. mRNAm5C Is Enriched in 5′UTRs of Human and Mouse.
To study the spatial organization of m5C sites in the
transcriptome, we ﬁrst analyzed the relative enrichment (see
Materials and Methods for more details) of m5C sites on
diﬀerent types of RNA and at diﬀerent regions (shown in
Figure 1(b)) by compensating for the cytosine sites that do
not carrym5Cmodiﬁcation.Our results showed thatm5Csites
were consistently and signiﬁcantly enriched at 5′UTRs in
human and mouse with enrichment odds ratio of 3.138,
4.802, 2.744, and 1.601 (please see Table S1 for more details).
The similar topology was already reported by previous studies
[35, 36], and our observation further conﬁrmed their
conclusions. Also, we did observe a slight enrichment of m5C
sites in 3′UTR in mouse brain (enrichment odds ratio = 1.013
and 1 19E − 02), which is also reported in the study of Amort
et al. [36]. 3′UTR enrichment was not observed in the other
samples (odds ratio = 0.964, 0.971, and 0.617).
To further substantiate these ﬁndings, we plotted the dis-
tribution of the methylated and unmethylated cytosine sites
located on mRNAs with the Guitar package [46]. In order
to improve the resolution of this analysis and diﬀerentiate
the distribution of m5C sites on usually short 5′UTRs, only
the mRNAs with a 5′UTR longer than 100 bp are used. As
shown in Figure 2(a), the methylated cytosine sites were
consistently enriched at 5′UTRs across all 4 samples when
compared to unmethylated groups. Interestingly, this trend
is also supported by the cytosine methylation sites reported
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Figure 1: Distribution of transcriptome m5C modiﬁcation sites in human and mouse. (a) The pie chart shows transcriptome-wide
distribution of m5C sites in MCF10A, MDA-MB-468, mouse embryonic stem cell (ESC), and whole brain. The majority of the identiﬁed
m5C sites are located on mRNAs. (b) Graph showing status of m5C frequency in diﬀerent regions of mRNA. The result indicates that
detected cytosine sites are consistently enriched at the 5′UTR on mRNA compared with the CDS and 3′UTR.
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Figure 2: Conservation of m5C in diﬀerent mRNA regions. (b) Graph showing the status of m5C frequency in diﬀerent regions of the
transcripts. We divided all the detected cytosine sites into 2 groups based on whether it is methylated. The result indicates that cytosine
sites with signiﬁcant methylation levels are consistently enriched at the 5′UTRs and near the start codon in all 4 samples. (b) A correlated
methylation pattern is observed on 5′UTRs between diﬀerent cell lines/tissues in human and mouse. The conserved cytosine residuals
were retrieved with liftOver utility (http://genome.ucsc.edu/cgi-bin/hgLiftOver), and the correlation analysis is performed with Fisher’s
exact test. It is important to note that, although we failed to observe a correlated m5C methylation pattern on CDSs and 3′UTRs of
mRNA, it is possible that such pattern may emerge on strictly matched cell lines/tissues.
6 International Journal of Genomics
by Squires et al. [35], and there is no signiﬁcant enrichment
of m5C sites observed in 3′UTR when all cytosine methylated
sites were used as background (Figure S3).
When we further compared the methylation status of the
conserved loci in human and mouse between diﬀerent cell
lines/tissues, we observed that, although the cell types/tissues
we used were not strictly matched, a strong correlated
methylation pattern was observed on the 5′UTR region
(Figure 2(b) and Table S2). However, unlike the 5′UTR, the
correlated pattern of m5C sites were not consistently
observed in CDSs or 3′UTRs in our study; the observed
heterogeneity of the m5C methylome in diﬀerent transcript
regions suggests that the m5C mapped to the 5′UTR of the
transcripts are more likely to be functionally important.
3.3. m5C Site Exists under Diﬀerent Nucleotide Contexts.
Because RNA methyltransferase Dnmt2 shares strong
sequence homology to all DNA DNMT methyltransferases
[52], we reason that exploring the relationship between tran-
scriptome and DNA m5C methylation proﬁles may unravel
interesting interplay between the two kinds of reversible
chemical modiﬁcations. In mammalian cells, DNA methyla-
tion occurs mainly at CG dinucleotides (including ACG,
CCG, TCG, and GCG, see Figure 3(b)). To study whether,
like DNA methylation, transcriptome m5C methylation also
occurs at the similar position, we analyzed methylated cyto-
sine in the transcriptome. For this purpose, we examined all
the possible C-centered trinucleotide combinations. Unlike
DNA, transcriptome m5C occurs at all C-centered trinucleo-
tides (Figure 3(a)) and was observed to be speciﬁcally
enriched at GCA, ACG, CCG, GCG, CCC, and GCC. These
results were found to be consistent within the same species
(Pearson correlation= 0.96 and 0.92, Figure 3(c)) and
between diﬀerent species (Pearson correlation= 0.72, 0.75,
0.45, and 0.48, Figure 3(c)).
3.4. Negative Correlation in Methylation Level Is Observed
between mRNA and the Corresponding Exonic Region of
DNA.We next examined whether there exists any correlation
between m5C methylated/nonmethylated (m5C methylation
ratio) in the transcriptome and corresponding DNA exonic
regions at each C-centered trinucleotide sites. Because DNA
methylation occurs mainly at CG dinucleotides, as expected,
we observed no strong correlation at non-CG trinucleotides.
However, we observed signiﬁcant negative correlation in
methylation ratios between RNA and DNA at all four CG-
containing trinucleotides. As a higher percentage of m5C in
mRNA is detected, the corresponding DNA exonic CG dinu-
cleotide was less likely to be methylated (Figure 4(a)). Next,
we grouped m5Cmethylated at all CG sites according to their
methylation ratio (methylated and unmethylated) and inves-
tigated their distributions in mRNA and the corresponding
exonic regions of DNA. Consistent with our previous ﬁnd-
ing, we observed a signiﬁcant negative correlation in both
human and mouse cells. In particular, 5′UTR in mRNA
showed a high methylation ratio, whereas the correspond-
ing DNA region showed a signiﬁcantly low methylation
ratio (Figure 4(b)).
3.5. Transcriptome m5C Sites Exhibit a Clustering Eﬀect. In
DNA methylation, it has been shown that the correlation of
methylation rates between two CpG sites is related to the dis-
tance (see Figure S4), and the clustering eﬀect can be as high
as 0.7 for probes within 200 bp [53]. To address whether the
mRNA m5C methylation also exhibits a clustering eﬀect, we
examined the proportion of m5C sites that are within 10 bp
distance of other m5C sites and compared this proportion
with that from 1000 times of random permutation. Our
analysis revealed that m5C showed an obvious clustering
eﬀect in both mRNA and DNA (Figures 5(a) and 5(b). In
the ESC cell line, more than 76.7% of the mRNA
methylation sites had at least one methylation site mapped
within the 10nt-ﬂanked region, compared with 7.7% of
such event by random permutation of methylation states on
insigniﬁcant methylation sites of the methylated genes. In
mouse ESC and brain cells, more than 43.02% and 30.06%
of mRNA m5C methylation sites existed within the m5C-p-
m5C dimmers, compared with expected rate of 1.02% and
0.77% of such dimmers by the random permutation.
To further elucidate the clustering eﬀect, we calculated
the correlation of the methylation ratio between two cyto-
sine sites with a speciﬁc distance. To our surprise, mRNA
methylation exhibited a stronger clustering eﬀect com-
pared with DNA (Figure 5(c)). In addition, the correlation
of the methylation ratio was consistently stronger within
1–3nt distance as revealed by the higher correlation of
the methylation ratio (0.76 in MCF10A and 0.79 in
ESC). These results indicated that most CpC dimers are
comethylated; the correlation of the methylation ratio
can be as high as 0.58 in MCF10A and 0.47 in ESC for
cytosine sites with a distance of 4–10 nt. Though the over-
all clustering eﬀect of DNA methylation was not as strong
as mRNA methylation, when only the CpG dinucleotide
was considered, DNA methylation exhibited a stronger
clustering eﬀect than mRNA methylation (see Figure S4).
3.6. Transcriptome m5C Is Strongly Enriched in Mitochondrial
Transcripts. To further establish a physiological relevance of
m5C distribution, we examined the methylation level of RNAs
encoded in diﬀerent chromosomes. Surprisingly, m5C modiﬁ-
cation was strongly enriched in RNAs transcribed speciﬁcally
from mitochondrial DNA in normal and breast cancer cells
as well as in mouse ESC and brain as revealed by enrichment
odds ratios of 818.42949, 634.72723, 1028.52065, and
67.28553, respectively. In contrast, the enrichment odds ratios
of RNA methylation for transcripts from other chromosomes
were found to be roughly the same (Figure 6(a)). The RNA
transcripts of all the major genes located on a mitochondrial
chromosome were signiﬁcantly methylated (Figure 6(b)).
Previously, it was reported that methyltransferase NSUN5
can regulate mitochondrial gene expression [54], and we
speculate that RNA m5C may play a more vital regulatory
role in mitochondria-related biological processes.
3.7. Dysregulation of RNA Methylome in Breast Cancer.
Comparison of normal (MCF10A) and breast cancer
(MDA-BM-468) m5C epitranscriptomes identiﬁed 162 sig-
niﬁcant diﬀerential methylation sites (DMSs) located on
7International Journal of Genomics
Brain RNA
ESC RNA
MDA468 RNA
MCF10A RNA
0.000
0.001
0.002
0.003
0.004
0.000
0.001
0.002
0.003
0.000
0.005
0.010
0.015
0.020
0.000
0.005
0.010
Pr
op
or
tio
n 
of
 m
5C
 si
te
s i
n 
RN
A
 
ACG
TCG
CCG
GCG
ACC
TCC
CCC
GCC
ACT
TCT
CCT
GCT
ACA
TCA
CCA
GCA
Nucleotide contexts
(a)
ESC DNA
MCF10A DNA
ACG
TCG
CCG
GCG
ACC
TCC
CCC
GCC
ACT
TCT
CCT
GCT
ACA
TCA
CCA
GCA
0.0
0.1
0.2
0.3
0.4
0.0
0.2
0.4
0.6
Nucleotide contexts
Pr
op
or
tio
n 
of
 m
5C
 si
te
s i
nD
N
A
(b)
Figure 3: Continued.
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47 annotated genes at a signiﬁcance level of 0.05. Among
the 47 diﬀerentially methylated genes, 35 shows hypome-
thylation and 12 shows hypermethylation in cancer cells
compared with the normal control cell line. The majority
of the diﬀerential methylation sites show hypomethylation
(Excel Sheet S1 and Figure 7(a)), and the m5C hypomethyla-
tions are mostly located in the CDS and 3′UTR region of
mRNA but not in the 5′UTR region (Figure 7(b)). We then
investigated whether diﬀerent m5CmRNAmethylation levels
in normal and breast cancer cells have any functional correla-
tion. We performed functional gene set enrichment analysis
on genes containing DMS using the DAVID web server and
found that many of the 47 diﬀerentially methylated genes
are related to important biological functions of cancer, for
example, regulation of apoptosis and programmed cell death
with RTN4, NME2, CASP14, HSPB1, RPL11, and RPS3 dif-
ferentially methylated (Excel Sheet S1).
Interestingly, like the diﬀerence between the breast can-
cer cell line MDA-MB-468 and the normal epicelial cell line
MCF10A, similar mechanistic mouse stem cells [55] also
exhibit dominant hypomethylation in the m5C epitranscrip-
tome when compared with mouse brain cells with 2513 genes
hypomethylated and 767 genes hypermethylated (Figure 7(c)
and Excel Sheet S2). Also similar to the previous case, the
hypomethylations are mostly located in the CDS and 3′
UTR regions of mRNA, but not in the 5′UTR region
(Figure 7(d)). Using DAVID, we found that hypermethylated
genes in ESC cells are mostly enriched with the regulation of
cell cycle (FZR1, E2F5, BOP1, TRRAP, CDK4, JUNB, etc.),
cell death (SIVA1, MCL1, YPEL3, ARF6, UBQLN1, SHF,
CIAPIN1, APLP1, GPX1, CASP3, etc.), and mRNA meta-
bolic process (SCAF1, FIP1L1, STRAP, RBM15B, CWC15,
XAB2, YBX1, AUH, SF3B2, APLP1, HNRNPL, etc.); the
hypomethylated genes are enriched with functions related
to ATP synthesis (ATP6V1F, ATP6V1C1, ATP6V0C,
ATP6V1A, ATP6V0E, ATP6V1E1, ATP5C1, etc.) and mito-
chondrial ribosome (MRPL15, MRPL27, MRPL16, MRPL36,
MRPL39, MRPL34, DAP3, etc.) (Excel Sheet S2). These
results may suggest that the m5C methylations are selectively
methylate transcripts having functions.
3.8. Positive Correlation between m5C mRNA Methylation
and Expression Changes. In our data, as the gene expression
is also estimated from RNA bisulﬁte-sequencing data, a direct
comparison of expression andm5Cmethylation changes may
be problematic due to dependent noise. To eliminate the inter-
ference of dependent noise between expression and methyla-
tion data, the samples are further divided for diﬀerent
purposes. Speciﬁcally, the 3 biological replicates are divided
into 2 groups, with 1 sample used for the estimation of expres-
sion changes and the other 2 samples for estimation of meth-
ylation changes. The expression changes and methylation
changes are then compared. This procedure was repeated for
3 times using diﬀerent grouping combinations.
A consistent and signiﬁcantly positive correlation is
observed (0.274, 0.303, and 0.254) between log2 expression
fold change and log2 methylation fold change when compar-
ing mouse embryo stem cells with brain cells (Figure S5),
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Figure 3: Comparative distributions of mRNA and DNA m5C methylation. (a) Bar graph shows the proportion of mRNA m5C sites under
diﬀerent combinations of C-centered trinucleotides in mouse and human cells. The dotted line shows the average percentage of methylation
under all trinucleotide contexts within the entire transcriptome. We observed that RNA m5C occurs under all trinucleotide contexts and is
slightly enriched in sequences containing CCG, GCG, GCC, GCU, and GCA. (b) Bar graph showing proportion of DNA m5C sites in
mouse and human cells. DNA cytosine sites were enriched exclusively in sequences containing CG dinucleotides (ACG, CCG, CCG, and
TCG). (c) The coeﬃcient of correlation between RNA methylation and trinucleotide sequences was found to be consistent between
samples from the same species (Pearson correlation = 0.96 for human and 0.92 for mouse) and also between human and mouse cells
(Pearson correlation = 0.72, 0.75, 0.45, and 0.48).
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Figure 4: The methylation ratio of corresponding m5C DNA and mRNA CpG islands shows negative correlation. (a) Negative correlation is
observed between DNA and mRNAmethylation ratio consistently under all four CG containing trinucleotides (ACG, TCG, CCG, and GCG)
in both human and mouse, that is, if a speciﬁc CG dinucleotide in DNA is methylated, the corresponding dinucleotide in mRNA is
signiﬁcantly less likely to be methylated. ∗The top 4 nucleotide contexts under which the strongest correlation between DNA and RNA
methylation level exists. (b) Comparative distributions of m5C methylated CG sites in DNA and RNA show an enrichment of sites with a
high methylation ratio in mRNA 5′UTR as opposed to an enrichment of low-methylation-ratio sites in DNA 5′UTR. The pattern is
consistent in both the human MCF10A cell line and mouse embryo stem cells.
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Figure 5: RNA m5C modiﬁcation exhibits a clustering eﬀect. (a) Bar graph shows the proportion of clustered m5C sites within 10 nt ﬂanked
regions. To evaluate the statistical signiﬁcance, we generated 1000 permutated results as a comparison with the bars indicating a 99%
conﬁdence interval. Using these criteria, m5C methylation showed a strong clustering eﬀect consistently on diﬀerent RNA families and on
diﬀerent regions of mRNA in human and mouse. Around 50% of the m5C sites were clustered with each other within a 10 bp region. (b)
DNA methylation also exhibited a clustering eﬀect. However, the pattern is not that strong when all nucleotide contexts are considered.
(c) Line graph showing correlation between RNA/DNA m5C methylation and distance between cytosine sites. RNA m5C methylation
showed strong correlation with cytosine sites that are immediately close to each other. The clustering eﬀect of DNA methylation is strong
when only CpG context is considered (Figure S4).
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suggesting that increased methylation level is likely to be
associated with increased expression level. Although the
speciﬁc molecular mechanism is not yet clear, the observed
positive correlation between RNA m5C and RNA expression
conﬁrmed our previous observed anticorrelation between
DNA and RNA m5C methylation (see Figure 4) from a
diﬀerent perspective.
To explain the positive correlation between expression
and transcriptomem5Cmethylation, we compared the meth-
ylation status of all the genes and their half-life, where the
half-life of mouse genes were obtained from a previous study
[56]. The mRNAs are classiﬁed into two groups based on
whether they have at least one m5C site or not. To exclude
the confounding factor (eﬀective size in methylation site call-
ing), a generalized linear model of the binomial family was
ﬁtted to the half-life with both expression and methylation
information. Our result suggests that there exists a signiﬁcant
positive correlation (p value = 2 23e − 12) between the
mRNA half-life and its m5C methylation status in mouse
embryo stem cells, and the positive association is also
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Figure 6: m5C is enriched on mRNAs transcribed from mitochondrial DNA. (a) Bar graph depicting m5C mRNA methylation sites on
diﬀerent chromosomes. RNAs transcribed from mitochondrial DNA (M) showed drastically increased frequency of m5C sites (enrichment
odds ratio of 818.42949, 634.72723, 1028.52065, and 67.28553). (b) Bar graph showing the number of methylated cytosine reads stacked
with unmodiﬁed cytosine reads generated from 6 major classes of mitochondrial genes. The RNA transcripts of all the major genes located
on a mitochondrial chromosome were signiﬁcantly methylated.
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conﬁrmed on mouse whole brain dataset (p value = 0.0374).
To further exclude the impact of mRNA expression in calling
methylation status, we also extracted the genes whose log2
expression levels fall between 7 and 11, and then ﬁt their
mRNA half-life with a local regression. As shown in
Figure 8, compared with the genes of a similar expression
level but without an m5C site, the half-life of the mRNAs that
carry m5C sites is clearly longer and the pattern is consistent
in both mouse brain and ESC.
3.9. Dysregulation of RNAMethylome after Simian Retrovirus
Infection. Simian retrovirus (SRV) infection of Jurkat T lym-
phocytes (Jurkat cells) was conﬁrmed by syncytia formation,
of which the membrane of the neighboring cells fused to one
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Figure 7: Diﬀerential m5C mRNA methylation in diﬀerent tissues. (a) Pie-diagram showing hypo- and hypermethylation in MDA468 when
compared to MCF10A. A total of 47 diﬀerential methylated genes were identiﬁed between the breast cancer (MDA-MB-468) and normal
control cell lines (MCF10A) with primary hypomethylation under cancer condition. (b) Bar graph showing odds ratio of
hypermethylation sites with respect to all diﬀerentially methylated sites on diﬀerent regions of mRNA. Hypermethylated sites were
strongly enriched in 5′UTRs. (c) Pie diagram showing hypermethylation in mouse embryo stem cells when compared to whole brain cells.
(d) Bar graph showing odds ratio of hypermethylation sites with respect to all diﬀerentially methylated sites on diﬀerent regions of mRNA
in the mouse experiment. Hypermethylated sites were strongly enriched in 5′UTRs.
13International Journal of Genomics
another. At 10 days postinfection, the formation of syncy-
tium was observed among the Jurkat cells incubated with
SRV (Figure 9(a)). The syncytium of Jurkat cells contains
multiple nuclei and its size is dramatically larger than a single
cell. SRV long terminal repeats (LTRs), which are reverse-
transcribed from the RNA genome during the infection,
contain critical sequences necessary for the integration,
synthesis, and expression of viral DNA [1]. Therefore,
the extent of SRV infection was assayed by monitoring
SRV-LTR expression in Jurkat cells through quantitative
real-time PCR. As shown in Figure 9(b), the copy number
of SRV-LTR was gradually increased from 2 days to 10
days postinfection and then tended to be stable afterwards.
Taken together, these results indicated that SRV was able
to infect Jurkat cells and the infection reached maximum
level after 10 days postinfection.
In order to investigate whether SRV could replicate in
Jurkat cells, the SRV virions released in the culture
medium were determined by measuring viral genome copy
number through quantitative real-time PCR. As shown in
Figure 9(c), the copy number of the SRV genome was
gradually increased from 2 days to 14 days postinfection,
suggesting that SRV was able to replicate in Jurkat cells.
We then measured the RNA methylome with bisulﬁte
sequencing. A total of 2475 m5C sites located on 517
genes are reported as diﬀerentially methylated 10 days
postinfection of SRV with QNB p value< 0.05. Among
them, 389 sites located on 158 genes are hypomethylated,
while 2086 sites from 382 genes are hypermethylated. A
gene ontology analysis using the DAVID website suggests
that the diﬀerentially methylated genes are related to virus
infection, speciﬁcally, hypermethylated genes are enriched
with DNA replication (p value = 6 07E − 5), mitotic nuclear
division (p value = 4 37E − 4), DNA replication initiation
(p value = 3 48E − 3), autophagosome assembly (p value
= 8 54E − 3), strand displacement (p value = 1 42E − 2),
double-strand break repair via homologous recombina-
tion (p value = 3 42E − 3), and so on, while hypomethy-
lated genes are enriched with the following biological
processes including negative regulation of epidermal
growth factor receptor signaling pathway (p value = 3 24E
− 3), DNA damage checkpoint (p value = 2 54E − 2), cell
migration (p value = 1 42E − 2), and so on (see Figure 9
and Excel Sheet S3). Similar to before, a positive correla-
tion (0.07) is observed between RNA methylation level
and expression level; however, as there are 23 genes that
carry hyper- and hypomethylated sites simultaneously, it
is expected that RNA m5C carries more complicated
biomolecular functions.
4. Discussion and Conclusion
The distribution of m5C methylation in mRNA has been
mysterious with inconsistent evidence reported from previ-
ous studies [35, 37]. Here, we proﬁled the human and mouse
m5C epitranscriptome using RNA BS-Seq data in human
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Figure 8: RNAm5C status is positively correlated with RNA half-life. In the above ﬁgure, each red dot represents a gene that carries m5C sites,
and each blue dot represents a gene that does not carry an m5C site. When comparing the methylated and unmethylated genes of similar
expression, the genes that carry an m5C site have longer RNA half-life than those that do not carry m5C sites. (a) Positive correlation
between RNA methylation status and RNA half-life is observed in mouse brain (p value = 0.0374, generalized linear model of binomial
family). (b) Positive correlation between RNA methylation status and RNA half-life is observed in mouse embryo stem cells (p value =
2 23E − 12, generalized linear model of binomial family).
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MCF10A, human MDA468, mouse ESC, and mouse whole
brain cells. To eliminate the data sample bias, we employed
a rigorous quality control procedure by ﬁltering false positive
m5C sites due to the secondary structure and performed a
comprehensive comparative analysis on cross-species con-
served locus, cross-sample comparison of topological
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Figure 9: Dysregulation of RNAmethylome after SRV infection of Jurkat cell. (a) At 10 days postinfection, uninfected or SRV-infected Jurkat
cells were stained with SRV antibodies (green). Nuclei were visualized by Hoechst staining (blue). Arrows indicate the syncytium of infected
cells. Scale bar: 50 μM. (b) The relative level of SRV-LTR in infected Jurkat cells was measured every two days by real-time PCR. GAPDH was
used as the internal control. The relative level of SRV-LTR at each time point was normalized to the data at 2 dpi; mean± SD, n = 3. (c) The
absolute copy number of the SRV genome in culture medium was measured every two days by real-time PCR. SRV-LTR and SRV genome
were not detected in all uninfected cells and culture medium, respectively; mean± SD, n = 3. (d) The diﬀerentially methylated genes are
enriched with the following functions including DNA replication (p value = 6 07E − 5), mitotic nuclear division (p value = 4 37E − 4), DNA
replication initiation (p value = 3 48E − 3), autophagosome assembly (p value = 8 54E − 3), strand displacement (p value = 1 42E − 2),
double-strand break repair via homologous recombination (p value = 3 42E − 3), and so on, while hypomethylated genes are enriched with
the following biological processes including negative regulation of epidermal growth factor receptor signaling pathway (p value = 3 24E − 3),
DNA damage checkpoint (p value = 2 54E − 2), cell migration (p value = 1 42E − 2), and so on (see Figure 9 and Excel Sheet S5). (e) A weak
but positive correlation (Pearson correlation = 0.07) is observed between RNA methylation level and expression level, which is consistent
with our previous result; however, there are 23 genes that carry hyper- and hypomethylated sites simultaneously, which implies that RNA
m5C carries more complicated biomolecular functions.
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transcriptome distributions of m5C, and diﬀerential m5C
analysis. Our analysis clearly shows that m5C is enriched at
the 5′UTR in human and mouse cells, conﬁrming the discov-
ery of a few independent studies [35, 36, 46]. Additionally, an
unambiguous correlated methylation pattern is observed on
5′UTRs, but not on CDS and 3′UTR, in diﬀerent mouse
and human cell lines/tissues, suggesting a more complex
aggregation pattern of m5C that may be further character-
ized. Together, these observations strongly imply the func-
tional relevance of m5C RNA methylation and 5′UTR of
mRNA. It is important to note that, although we failed to
observe a correlated m5C methylation pattern on CDS and
3′UTR regions of mRNA, it is still possible that such pattern
may emerge on strictly matched cell lines/tissues.
When comparing the DNA and RNA methylome in
matched cell lines in human and mouse, a negative correla-
tion in the methylation level is observed on matched locus
on DNA and RNA, which is quite surprising given that the
methyltransferase of DNA and RNA may share strong
sequence homology [52]. This anticorrelation pattern is con-
sistent at all four CG-containing trinucleotide contexts and
ruled out the possibility of sample contamination or oﬀ-
target eﬀect, which should both lead to false positive correla-
tion in data. It is possible that there exists an underlying
biomolecular mechanism that functions on the matched
locus of DNA and RNA in parallel to ensure their orches-
trated methylation status.
Similar to DNA methylation, a clustering eﬀect of m5C
on mRNA is also observed in both human and mouse. The
local dependency, that is, the adjacent cytosine locus often
exhibits a similar methylation status, has been widely used
in DNA methylation data analysis for more robust and accu-
rate quantiﬁcation of epigenetics status [57–59]. It is reason-
able to expect that similar statistical approaches may be
carried over into the ﬁeld of single-base resolution RNA
methylation data to enhance the analysis of bisulﬁte RNA
methylation sequencing data. It is worth mentioning that,
around 30%–43% of m5C residuals exist in pairs in our
results after ﬁltering potential secondary structures that
may lead to incomplete conversion and false positive m5C
sites. The number may be over- or underestimated because
of the unﬁltered secondary structure, which leads to an over-
estimation of the clustering eﬀect, and structured regions
excluded from the analysis, which may aﬀect the estimation
in both directions. It is necessary to develop a more sensitive
unbiased approach that can eliminate the impact of the RNA
structure to more accurately assess the distribution of tran-
scriptome m5C modiﬁcation.
Intriguingly, we observed a strong enrichment of m5C
methylation on mitochondrial transcripts with more than
50 folds of enrichment. Previously, it was reported that meth-
yltransferase NSUN5 can regulate mitochondrial gene
expression [54], and we speculate that RNA m5C methyla-
tion may play a more vital regulatory role in mitochondria-
related biological processes.
Additionally, in order to have a glimpse of the dynamics
of m5C onmRNA, diﬀerential RNAmethylation analysis was
performed between breast cancer cell line MDA-MB-468 and
the control cell line MCF10A; a total of 47 genes are reported
to be diﬀerentially methylated, including RTN4, NME2,
CASP14, HSPB1, RPL11, and RPS3, which are related to apo-
ptosis and programmed cell death. Although we showed pre-
viously that m5C onmRNA are more likely to be linked to the
5′UTR function, it is observed that the diﬀerential methyla-
tion sites between the breast cancer cell line and normal con-
trol cell lines are mostly located on the CDS and 3′UTR.
These observations together implied a profound role of
m5C methylation on diﬀerent regions of mRNA and in
cancer pathology.
Interestingly, an overall positive correlation between
RNAm5Cmethylation and RNA expression level is observed
in our mouse and human datasets, which added to the grow-
ing importance of mRNA m5C methylation in regulating
gene expression. Although the speciﬁc molecular mechanism
is not yet clear, the observed positive correlation between
RNA m5C and RNA expression echoes our previous
observed anticorrelation between DNA and RNAm5Cmeth-
ylation from a diﬀerent perspective, because it has been well
established that DNA methylation is anticorrelated with
RNA expression. However, as it is known that the most
abundant RNA modiﬁcation m6A methylation may
enhance or reduce the stability of the RNA molecule
through interaction with diﬀerent m6A readers [14, 60]
or regulate RN-protein interaction [13], it is reasonable
to assume that RNA m5C may have versatile functionali-
ties, and may get dominated by a distinct mechanism
under a speciﬁc condition.
In summary, our study presented an in-depth topological
characterization of the m5C RNA methylome in human and
mouse. There are interesting patterns depicted and
quantiﬁed, which call for further studies to explain novel
biomolecular mechanisms.
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